<SUBMISSION>
<SECRELEASE-DATETIME> 20130308-141119 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20130308-141119 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20130308-141040 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001213900-13-001007
<TYPE> 8-K
<PUBLIC-DOCUMENT-COUNT> 2
<PERIOD> 20130304
<ITEMS> 4.01
<ITEMS> 9.01
<FILING-DATE> 20130308
<DATE-OF-FILING-DATE-CHANGE> 20130308
|
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME> Caldera Pharmaceuticals Inc
<CIK> 0001518520
<ASSIGNED-SIC> 8731
<IRS-NUMBER> 200982060 ⇒ 20-0982060
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> 8-K
<ACT> 34
<FILE-NUMBER> 000-54748
<FILM-NUMBER> 13676611
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 278 DP ROAD SUITE D
<CITY> LOS ALAMOS
<STATE> NM
<ZIP> 87544
<PHONE> 505-661-2420
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 278 DP ROAD SUITE D
<CITY> LOS ALAMOS
<STATE> NM
<ZIP> 87544
</MAIL-ADDRESS>
</FILER>
|
<DOCUMENT>
<TYPE> 8-K
<SEQUENCE> 1
<FILENAME> f8k030413_caldera.htm
<DESCRIPTION> CURRENT REPORT
<TEXT>
<html>
Show <HTML>: 368 lines (widest: 868 characters) - 32K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-16.1
<SEQUENCE> 2
<FILENAME> f8k030413ex16i_caldera.htm
<DESCRIPTION> LETTER DATED MARCH 8, 2013 FROM SHERB & CO., LLP TO THE
SECURITIES AND EXCHANGE COMMISSION.
<TEXT>
<html>
Show <HTML>: 43 lines (widest: 352 characters) - 3K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
